JiuZhou Pharma Retains EcoVadis Gold Rating, Ranking Among the Top 5% Globally
Release time:
2026-03-09
Recently, JiuZhou Pharma was once again awarded the EcoVadis Gold Rating. This marks the third consecutive year that JiuZhou Pharma has participated in the EcoVadis assessment at the group level, and the second consecutive year the company has achieved the prestigious Gold rating.
EcoVadis is a leading global sustainability rating platform that evaluates companies across four key areas: Environment, Labor & Human Rights, Ethics, and Sustainable Procurement. As more customers establish stringent ESG standards in their supplier selection processes, ratings such as EcoVadis have increasingly become an important factor in decision-making.
In the latest assessment, JiuZhou Pharma once again ranked among the top 5% of companies globally. This strong EcoVadis rating not only demonstrates to our customers, partners, and investors that we take sustainability seriously, but also reflects JiuZhou Pharma’s globally leading performance in environmental, social, and governance (ESG) management.
Other News
JiuZhou Pharma Retains EcoVadis Gold Rating, Ranking Among the Top 5% Globally
Recently, JiuZhou Pharma was once again awarded the EcoVadis Gold Rating. This marks the third consecutive year that JiuZhou Pharma has participated in the EcoVadis assessment at the group level, and the second consecutive year the company has achieved the prestigious Gold rating.
EcoVadis is a leading global sustainability rating platform that evaluates companies across four key areas: Environment, Labor & Human Rights, Ethics, and Sustainable Procurement. As more customers establish stringent ESG standards in their supplier selection processes, ratings such as EcoVadis have increasingly become an important factor in decision-making.
In the latest assessment, JiuZhou Pharma once again ranked among the top 5% of companies globally. This strong EcoVadis rating not only demonstrates to our customers, partners, and investors that we take sustainability seriously, but also reflects JiuZhou Pharma’s globally leading performance in environmental, social, and governance (ESG) management.
2026-03-09
Digital Transformation in Clinical Research Services Enhances Trial Quality
Recently, JiuZhou Pharma was once again awarded the EcoVadis Gold Rating. This marks the third consecutive year that JiuZhou Pharma has participated in the EcoVadis assessment at the group level, and the second consecutive year the company has achieved the prestigious Gold rating.
EcoVadis is a leading global sustainability rating platform that evaluates companies across four key areas: Environment, Labor & Human Rights, Ethics, and Sustainable Procurement. As more customers establish stringent ESG standards in their supplier selection processes, ratings such as EcoVadis have increasingly become an important factor in decision-making.
In the latest assessment, JiuZhou Pharma once again ranked among the top 5% of companies globally. This strong EcoVadis rating not only demonstrates to our customers, partners, and investors that we take sustainability seriously, but also reflects JiuZhou Pharma’s globally leading performance in environmental, social, and governance (ESG) management.
2026-03-09
Small Molecule API Manufacturing Upgrades Enhance Pharmaceutical Supply Stability
Recently, JiuZhou Pharma was once again awarded the EcoVadis Gold Rating. This marks the third consecutive year that JiuZhou Pharma has participated in the EcoVadis assessment at the group level, and the second consecutive year the company has achieved the prestigious Gold rating.
EcoVadis is a leading global sustainability rating platform that evaluates companies across four key areas: Environment, Labor & Human Rights, Ethics, and Sustainable Procurement. As more customers establish stringent ESG standards in their supplier selection processes, ratings such as EcoVadis have increasingly become an important factor in decision-making.
In the latest assessment, JiuZhou Pharma once again ranked among the top 5% of companies globally. This strong EcoVadis rating not only demonstrates to our customers, partners, and investors that we take sustainability seriously, but also reflects JiuZhou Pharma’s globally leading performance in environmental, social, and governance (ESG) management.
2026-03-02
Business Collaboration
Innovative Drug CDMO Services
Tel: 86-576-85588039 / 86-576-85580090
E-mail: bd@jiuzhoupharma.com
